Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | FABP3 | P05413 | 2/20 | 0.45 |
| ▸ | FABP7 | O15540 | 1/20 | 0.45 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.45 |
| ▸ | SYK | P43405 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.45 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8986479 | 0.87 | FABP3 (0.53) | LMNAL3MBTL1TDP1MAPK1ALDH1A1 | |
| SCHEMBL236823 | 0.87 | FABP3 (0.53) | LMNAL3MBTL1TDP1MAPK1ALDH1A1 | |
| SCHEMBL1639323 | 0.87 | FABP3 (0.56) | LMNAL3MBTL1TDP1MAPK1ALDH1A1 | |
| SCHEMBL30563023 | 0.87 | FABP3 (0.56) | LMNAL3MBTL1TDP1MAPK1ALDH1A1 | |
| SCHEMBL867780 | 0.86 | MAOB (0.52) | LMNAL3MBTL1TDP1MAPK1ALDH1A1 | |
| SCHEMBL709954 | 0.86 | LMNA (0.51) | LMNAL3MBTL1TDP1MAPK1ALDH1A1 | |
| SCHEMBL27678114 | 0.84 | L3MBTL1 (0.43) | LMNAL3MBTL1TDP1MAPK1ALDH1A1 | |
| SCHEMBL7647143 | 0.84 | LMNA (0.50) | LMNAL3MBTL1TDP1MAPK1ALDH1A1 | |
| SCHEMBL8059091 | 0.84 | FABP3 (0.46) | LMNAL3MBTL1TDP1ALDH1A1FABP3 | |
| SCHEMBL7024866 | 0.84 | FFAR4 (0.47) | LMNAL3MBTL1TDP1MAPK1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1169289-B1 | METHOD FOR PRODUCING DERIVATIVES OF BIPHENYL-2-CARBOXYLIC ACID | BOEHRINGER INGELHEIM PHARMA (DE) | 2003-10-29 | — | — | EP | claimed |
| EP-1169289-A1 | METHOD FOR PRODUCING DERIVATIVES OF BIPHENYL-2-CARBOXYLIC ACID | Boehringer Ingelheim Pharma KG (DE) | 2002-01-09 | — | — | EP | claimed |
| WO-2000051961-A1 | METHOD FOR PRODUCING DERIVATIVES OF BIPHENYL-2-CARBOXYLIC ACID | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2000-09-08 | — | — | WO | claimed |
| US-9012676-B2 | Processes for producing aryl carbamates, isocynates and polyureas using diaryl carbonate | GREAT EASTERN RESINS INDUSTRIAL CO., LTD. (CN) | 2015-04-21 | — | — | US | disclosed |
| US-20130079542-A1 | PROCESSES FOR PRODUCING ARYL CARBAMATES, ISOCYNATES AND POLYUREAS USING DIARYL CARBONATE | NATIONAL CHUNG HSING UNIVERSITY (TW) | 2013-03-28 | — | — | US | disclosed |
| EP-1210322-B1 | METHOD FOR CARRYING OUT THE SIDE CHAIN BROMINATION OF 4-METHYL BIPHENYL DERIVATIVES SUBSTITUTED AT THE 2'-POSITION | BOEHRINGER INGELHEIM PHARMA (DE) | 2005-02-09 | — | — | EP | disclosed |
| EP-1169289-B1 | METHOD FOR PRODUCING DERIVATIVES OF BIPHENYL-2-CARBOXYLIC ACID | BOEHRINGER INGELHEIM PHARMA (DE) | 2003-10-29 | — | — | EP | disclosed |
| WO-2003066565-A1 | DEUTERATED BIPHENYL DERIVATIVES | TURICUM DRUG DEVELOPMENT AG (CH) | 2003-08-14 | — | — | WO | disclosed |
| WO-2003066626-A1 | DEUTERATED BIPHENYL-SUBSTITUTED BENZIMIDAZOLES AND MEDICAMENT CONTAINING SAID COMPOUNDS FOR THE TREATMENT OF HYPERTONIA | TURICUM DRUG DEVELOPMENT AG (CH) | 2003-08-14 | — | — | WO | disclosed |
| EP-1102738-B1 | METHOD FOR THE ACIDIC OR ALKALINE SAPONIFICATION OF BIPHENYL NITRILES | LEHMANN BERND DR (DE) | 2002-12-04 | — | — | EP | disclosed |
| EP-1169289-A1 | METHOD FOR PRODUCING DERIVATIVES OF BIPHENYL-2-CARBOXYLIC ACID | Boehringer Ingelheim Pharma KG (DE) | 2002-01-09 | — | — | EP | disclosed |
| EP-1102738-A1 | METHOD FOR THE ACIDIC OR ALKALINE SAPONIFICATION OF BIPHENYL NITRILES | Great Lakes Chemical Konstanz GmbH (DE) | 2001-05-30 | — | — | EP | disclosed |
| US-6143917-A | FROM A DIARYL CARBONATE AND AN AMINE COMPOUND HAVING AT LEAST ONE HYDROGEN ATOM LOCATED AT AN N-POSITION UNDER MODERATE CONDITIONS AT A HIGH REACTION RATE WITH A HIGH SELECTIVITY AND WITH A HIGH YIELD | UBE INDUSTRIES, LTD. (JP) | 2000-11-07 | — | — | US | disclosed |
| WO-2000051961-A1 | METHOD FOR PRODUCING DERIVATIVES OF BIPHENYL-2-CARBOXYLIC ACID | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000003964-A1 | METHOD FOR THE ACIDIC OR ALKALINE SAPONIFICATION OF BIPHENYL NITRILES | GREAT LAKES CHEMICAL KONSTANZ GMBH (DE) | 2000-01-27 | — | — | WO | disclosed |
| EP-0902014-A1 | PROCESS FOR PRODUCING ARYL CARBAMATES | UBE INDUSTRIES LIMITED (JP) | 1999-03-17 | — | — | EP | disclosed |
| WO-1991013063-A1 | NEW BENZIMIDAZOLE DERIVATIVES, METHOD FOR PREPARING THEM AND THEIR PHARMACEUTICAL USE | SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) | 1991-09-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079542-A1 | PROCESSES FOR PRODUCING ARYL CARBAMATES, ISOCYNATES AND POLYUREAS USING DIARYL CARBONATE | UROD, DDC, TST | LMNA 1353/4885L3MBTL1 4521/4885TDP1 2593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.